Multimodality treatment for brain arteriovenous malformation in Mainland China: design, rationale, and baseline patient characteristics of a nationwide multicenter prospective registry

[1]  J. Mocco,et al.  2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage: A Guideline From the American Heart Association/American Stroke Association. , 2022, Stroke.

[2]  A. Islim,et al.  External validation of brain arteriovenous malformation haemorrhage scores, AVICH, ICH and R2eD , 2022, Acta Neurochirurgica.

[3]  Pingting Chen,et al.  Quantitative evaluation of hemodynamics after partial embolization of brain arteriovenous malformations , 2021, Journal of NeuroInterventional Surgery.

[4]  Shuo Wang,et al.  Long-term outcomes of brainstem arteriovenous malformations after different management modalities: a single-centre experience , 2020, Stroke and vascular neurology.

[5]  A. Moskowitz,et al.  Medical management with interventional therapy versus medical management alone for unruptured brain arteriovenous malformations (ARUBA): final follow-up of a multicentre, non-blinded, randomised controlled trial , 2020, The Lancet Neurology.

[6]  Shuo Wang,et al.  Contemporary management of brain arteriovenous malformations in mainland China: a web-based nationwide questionnaire survey , 2020, Chinese Neurosurgical Journal.

[7]  Rong Wang,et al.  Quantitative Angiographic Hemodynamic Evaluation After Revascularization Surgery for Moyamoya Disease , 2020, Translational Stroke Research.

[8]  J. Caron,et al.  Microsurgery for Unruptured Cerebral Arteriovenous Malformations in the National Inpatient Sample Is More Common Post-ARUBA. , 2020, World neurosurgery.

[9]  C. Ogilvy,et al.  Multimodal cerebral arteriovenous malformation treatment: a 12-year experience and comparison of key outcomes to ARUBA. , 2020, Journal of neurosurgery.

[10]  R. Du,et al.  The Ruptured Arteriovenous Malformation Grading Scale (RAGS): An Extension of the Hunt and Hess Scale to Predict Clinical Outcome for Patients With Ruptured Brain Arteriovenous Malformations. , 2020, Neurosurgery.

[11]  Y. Kao,et al.  Stasis index from hemodynamic analysis using quantitative DSA correlates with hemorrhage of supratentorial arteriovenous malformation: a cross-sectional study. , 2020, Journal of neurosurgery.

[12]  G. Pavesi,et al.  Expert Consensus on the Management of Brain Arteriovenous Malformations , 2019, Asian journal of neurosurgery.

[13]  Judy Huang,et al.  Updates in arteriovenous malformation management: the post-ARUBA era , 2019, Stroke & Vascular Neurology.

[14]  T. Krings,et al.  Predictive Value of MRI in Diagnosing Brain AVM Recurrence after Angiographically Documented Exclusion in Children , 2019, American Journal of Neuroradiology.

[15]  H. Jokura,et al.  The NASSAU (New ASSessment of cerebral Arteriovenous Malformations yet Unruptured) Analysis: Are the Results From The ARUBA Trial Also Applicable to Unruptured Arteriovenous Malformations Deemed Suitable for Gamma Knife Surgery? , 2018, Neurosurgery.

[16]  A. Weill,et al.  The Treatment of Brain AVMs Study (TOBAS): an all-inclusive framework to integrate clinical care and research. , 2017, Journal of neurosurgery.

[17]  C. Hess,et al.  Higher Flow Is Present in Unruptured Arteriovenous Malformations With Silent Intralesional Microhemorrhages , 2017, Stroke.

[18]  Jason P Sheehan,et al.  Management of Brain Arteriovenous Malformations: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association , 2017, Stroke.

[19]  E. Connolly,et al.  Arteriovenous Malformations of the Brain , 2007 .

[20]  M. Tymianski,et al.  Microsurgery for ARUBA Trial (A Randomized Trial of Unruptured Brain Arteriovenous Malformation)–Eligible Unruptured Brain Arteriovenous Malformations , 2017, Stroke.

[21]  A. Weill,et al.  Treatment of Brain AVMs (TOBAS): study protocol for a pragmatic randomized controlled trial , 2015, Trials.

[22]  Dean Y. Li,et al.  Brain arteriovenous malformations , 2015, Nature Reviews Disease Primers.

[23]  C. Warlow,et al.  Outcome after conservative management or intervention for unruptured brain arteriovenous malformations. , 2014, JAMA.

[24]  Joachim Berkefeld,et al.  Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial , 2014, The Lancet.

[25]  C. Warlow,et al.  A systematic review of the frequency and prognosis of arteriovenous malformations of the brain in adults. , 2001, Brain : a journal of neurology.

[26]  R F Spetzler,et al.  A proposed grading system for arteriovenous malformations. , 1986, Journal of neurosurgery.

[27]  G. Beeson,et al.  in adults with , 2019 .